Talis Biomedical Corp
General ticker "TLIS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.2M
Talis Biomedical Corp does not follow the US Stock Market performance with the rate: -33.8%.
Estimated limits based on current volatility of 3.4%: low 1.70$, high 1.82$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Current price 60.0% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.25$, 12.21$]
- 2024-12-30 to 2025-12-30 estimated range: [3.57$, 10.38$]
Financial Metrics affecting the TLIS estimates:
- Negative: Non-GAAP EPS, $ of -34.18 <= 0.10
- Negative: Operating profit margin, % of -99.39 <= 1.03
- Negative: Operating cash flow per share per price, % of -78.74 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: 0 < Industry inventory ratio change (median), % of 0.19
Short-term TLIS quotes
Long-term TLIS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $8.19MM | $4.81MM | $0.41MM |
| Operating Expenses | $200.01MM | $119.95MM | $67.23MM |
| Operating Income | $-191.82MM | $-115.14MM | $-66.81MM |
| Non-Operating Income | $-0.22MM | $2.13MM | $4.81MM |
| R&D Expense | $157.59MM | $70.83MM | $40.69MM |
| Income(Loss) | $-192.04MM | $-113.01MM | $-62.01MM |
| Profit(Loss) | $-192.04MM | $-113.01MM | $-62.01MM |
| Stockholders Equity | $233.98MM | $126.74MM | $69.12MM |
| Assets | $265.83MM | $169.29MM | $94.67MM |
| Operating Cash Flow | $-171.38MM | $-100.14MM | $-53.24MM |
| Capital expenditure | $2.87MM | $1.61MM | $0.49MM |
| Investing Cash Flow | $-2.87MM | $-1.61MM | $-0.49MM |
| Financing Cash Flow | $234.43MM | $0.41MM | $0.03MM |
| Earnings Per Share* | $-126.13 | $-62.45 | $-34.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.